The Patent Finder
US

Multimeric Oligonucleotide Compounds

US 10,093,924 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Sep 14, 2032 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jan 26, 2017 as application 15/416,100 · Granted Oct 9, 2018
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Sep 14, 2012
Ends no later than
Sep 14, 2032
Granted
Oct 9, 2018
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 14, 2012, when application PCT/US2012/055535, the earliest non-provisional in its chain, was filed (this one was filed Jan 26, 2017); a parent in its chain could not be resolved (the next row)Sep 14, 2032High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Sep 14, 2032Low confidence

Partial family

Application PCT/US2012/055535PCT application
no patent term
no patent term
US 9,580,708In force
Sep 2032
Sep 2032
US 9,732,340In force
no later than Sep 2032
no later than Sep 2032
US 9,732,341In force
no later than Sep 2032
no later than Sep 2032
US 10,093,924this patent
no later than Sep 2032
no later than Sep 2032
US 10,704,046In force
no later than Sep 2032
no later than Sep 2032
Partial: 1 of the 6 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 27, 2017
Reel 41098, frame 902
Subramanian, Romesh R.Pfizer, Inc.Assignment of Assignor's Interest
Jan 27, 2017
Reel 41098, frame 889
Rockel, Thomas Dino; Weber, Markus; Uhlmann, EugenColey Pharmaceutical GmbHAssignment of Assignor's Interest
Jan 27, 2017
Reel 41098, frame 912
Pfizer Inc.; Coley Pharmaceutical GmbHRana Therapeutics, Inc.Assignment of Assignor's Interest
Jan 27, 2017
Reel 41519, frame 767
Uhlmann, Eugen; Subramanian, Romesh; Krieg, Arthur M.Rana Therapeutics, Inc.Assignment of Assignor's Interest
Sep 1, 2017
Reel 43749, frame 575
Rana Therapeutics, Inc.Rana Development, Inc.Change of Name
Sep 1, 2017
Reel 43749, frame 387
Rana Development, Inc.Translate Bio Ma, Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited